Kestra Private Wealth Services LLC Trims Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Kestra Private Wealth Services LLC lowered its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXXGet Rating) by 18.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,507 shares of the company’s stock after selling 346 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in IDEXX Laboratories were worth $824,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Renaissance Technologies LLC acquired a new stake in shares of IDEXX Laboratories in the fourth quarter valued at $4,807,000. O Shaughnessy Asset Management LLC grew its stake in shares of IDEXX Laboratories by 3.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 11,901 shares of the company’s stock valued at $7,836,000 after buying an additional 371 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of IDEXX Laboratories by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 1,799,521 shares of the company’s stock valued at $1,182,485,000 after buying an additional 31,403 shares in the last quarter. Fullerton Fund Management Co Ltd. grew its stake in shares of IDEXX Laboratories by 57.1% in the fourth quarter. Fullerton Fund Management Co Ltd. now owns 17,676 shares of the company’s stock valued at $11,639,000 after buying an additional 6,426 shares in the last quarter. Finally, Schroder Investment Management Group grew its stake in IDEXX Laboratories by 9.2% during the 4th quarter. Schroder Investment Management Group now owns 160,377 shares of the company’s stock worth $105,602,000 after purchasing an additional 13,473 shares in the last quarter. Hedge funds and other institutional investors own 88.45% of the company’s stock.

IDEXX Laboratories Trading Down 2.1 %

NASDAQ:IDXX opened at $342.56 on Friday. IDEXX Laboratories, Inc. has a 1 year low of $318.50 and a 1 year high of $689.95. The company has a debt-to-equity ratio of 1.68, a quick ratio of 0.61 and a current ratio of 0.89. The stock has a market cap of $28.52 billion, a P/E ratio of 44.20, a P/E/G ratio of 4.66 and a beta of 1.16. The stock has a 50-day simple moving average of $373.36 and a 200-day simple moving average of $413.90.

Analyst Upgrades and Downgrades

IDXX has been the subject of several analyst reports. Morgan Stanley lowered their target price on IDEXX Laboratories from $603.00 to $573.00 and set an “overweight” rating for the company in a research note on Thursday, August 4th. Piper Sandler lowered their target price on IDEXX Laboratories from $500.00 to $420.00 in a research note on Monday, August 8th. StockNews.com raised IDEXX Laboratories from a “hold” rating to a “buy” rating in a research note on Monday, September 5th. Atlantic Securities lowered their target price on IDEXX Laboratories from $500.00 to $490.00 and set an “overweight” rating for the company in a research note on Wednesday, August 3rd. Finally, Barclays lowered their target price on IDEXX Laboratories from $700.00 to $582.00 and set an “overweight” rating for the company in a research note on Friday, August 5th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, IDEXX Laboratories presently has a consensus rating of “Moderate Buy” and an average target price of $483.57.

IDEXX Laboratories Company Profile

(Get Rating)

IDEXX Laboratories, Inc develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Further Reading

Want to see what other hedge funds are holding IDXX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXXGet Rating).

Institutional Ownership by Quarter for IDEXX Laboratories (NASDAQ:IDXX)

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.